Levels of evidence according to SIGN1 are indicated in a bracket () after each relevant reference.

  • 1
    Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001;323:334336 (4).
  • 2
    Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier B, Lockey R et al. A revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of World Allergy Organization. J Allergy Clin Immunol 2004;113:832836 (4).
  • 3
    Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999;353:11571158 (3).
  • 4
    Weiler JM. Anaphylaxis in the general population: a frequent and occasionally fatal disorder that is underrecognized. J Allergy Clin Immunol 1999;104: 271273 (4).
  • 5
    Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A et al. Second symposium on the definition management of anaphylaxis: summary report-Second National Institute of and Infectious Disease/Food Allergy Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391397 (4).
  • 6
    Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted Country: a population-based study. J Allergy Clin Immunol 1999;104:452456 (3).
  • 7
    Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005;60:443451 (4).
  • 8
    Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000;320:1441 (2-).
  • 9
    Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2007;62: 9196 (2-).
  • 10
    Bohlke K, Davis RL, De Stefano F, Mary SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004;113: 536542 (3).
  • 11
    Braganza SC, Acworth JP, Mckinnon DR, Peake JE, Brown AF. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006;91:159163 (3).
  • 12
    Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child 2002;86:236239 (3).
  • 13
    Clark AT, Ewan PW. Food allergy in childhood. Arch Dis Child 2004;89:197 (4).
  • 14
    Moneret-Vautrin DA, Romano MC, Kanny G, Morisset M, Beaudouin E, Parisot L et al. Le Projet d’Accueil Individualisé pour urgence allergique: situation en France métropolitaine et dans les Dom-Tom en 2002. Presse Med 2003;32:6166 (3).
  • 15
    Morritt J, Aszkenasy M. The anaphylaxis problem in children: community management in a UK National Health Service district. Public Health 2000;14:456459 (3).
  • 16
    Simons F, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002;110:647651 (2-).
  • 17
    Novembre E, Cianferoni A, Bernardini R, Mugnaini L, Caffarelli C, Cavagni G et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics 1998;101:816 (2-).
  • 18
    Bock SA, Munoz-Furlong A, Sampson HA. Fatalities dues to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191193 (3).
  • 19
    Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children – a questionnaire based survey in Germany. Allergy 2005;60:14401445 (3).
  • 20
    Mertes PM, Laxenaire MC. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Resp 2004;4:716 (3).
  • 21
    Karila C, Brunet-Langot D, Labbez F, Jacqmarcq O, Ponvert C, Paupe J et al. Anaphylaxis during anesthesia: results of a 12-year survey at a French pediatric center. Allergy 2005;60:828834 (2+).
  • 22
    Beaudouin E, Prestat F, Schmitt M, Kanny G, Laxenaire MC, Moneret-Vautrin DA. High risk of sensitization to latex in children with spina bifida. Eur J Pediatr Surg 1994;4:9093 (3).
  • 23
    Gold M, Swartz JS, Braude BM, Dolovich J, Shandling BRG. Intraoperative anaphylaxis: an association with latex sensitivity. J Allergy Clin Immunol 1991;87:662666 (3).
  • 24
    Tucke J, Posch A, Baur X, Rieger C, Rauf-Heimsoth M. Latex type I sensitization and allergy in children with atopic dermatitis evaluation of cross-reactivity to some foods. Pediatr Allergy Immunol 1999;10:160167 (2-).
  • 25
    Berstein DI, Wanner M, Borish L, Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions toallergen injections and skin testing: 1990–2001. J Allergy Clin Immunol 2004;113:11291136 (2-).
  • 26
    Lenchner K. Idiopathic anaphylaxis. Current Opin Allergy Clin Immunol 2003;3:305311 (4).
  • 27
    Brown A, Mckinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001;108:861866 (3).
  • 28
    Helbing A, Hurmi T, Mueller LR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940.000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004;34:285290 (3).
  • 29
    Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30:11441150 (3).
  • 30
    Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004;114: 371376 (3).
  • 31
    Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380384 (3).
  • 32
    Dibs S, Baker M. Anaphylaxis in children: a 5-year experience. Pediatrics 1997;99:15 (3).
  • 33
    Sampson HA. Anaphylaxis and emergency treatment. Pediatrics 2003;111S:16011607 (4).
  • 34
    Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000;106:762766 (2).
  • 35
    Sampson HA. Fatal food-induced anaphylaxis. Allergy 1998;53(Suppl. 46):125130 (3).
  • 36
    Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005;95:217226 (2++).
  • 37
    Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol 2007;98:6469 (2++).
  • 38
    Romano A, Di Fonso M, Giuffreda F, Papa G, Artesani MC, Viola M et al. Food-dependent exercise-induced anaphylaxis: clinical and laboratory findings in 54 subjects. Int Arch Allergy Immunol 2001;125:264272 (2+).
  • 39
    Tewari A, Du Toit G, Lack G. The difficulties of diagnosing food-dependent exercise-induced anaphylaxis in childhood – a case study and review. Pediatr Allergy Immunol 2006;17:157160 (4).
  • 40
    Lantner R, Reisman RE. Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis. J Allergy Clin Immunol 1989;84:900906 (3).
  • 41
    Mullins RJ. Anaphylaxis : risk factors for recurrence. Clin Exp Allergy 2003;33:10331040 (2-).
  • 42
    Pumphrey RS, Stanworth SJ. The clinical spectrum of anaphylaxis in northwest England. Clin Exp Allergy 1996;26:13641370 (3).
  • 43
    Hourihane JO, Grimshaw KE, Lewis SA, Briggs RA, Trewin JB, King† RM et al. Does severity of low-dose, double-blind, placebo-controlled, food challenge reflect severity of allergic reactions to peanut in the community. Clin Exp Allergy 2005;35:12271233 (2-).
  • 44
    Vander Leek TK, Liu AH, Stefanski K, Blacker B, Bock SA. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr 2000;137:749755 (2+).
  • 45
    Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction?. Curr Opin Allergy Clin Immunol 2004;4: 285290 (4).
  • 46
    Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004;113:837844 (4).
  • 47
    Gu X, Simons FE, Simons KJ. Epinephrine absorption after different routes of administration in an animal model. Biopharm Drug Dispos 1999;20:401405 (1-).
  • 48
    Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol 2000;106:171176 (2-).
  • 49
    Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 2000;105:359362 (2++).
  • 50
    Krugman SD, Chiaramonte DR, Matsui EC. Diagnosis and management of food-induced anaphylaxis: a national survey of pediatricians. Pediatrics 2006;118:e554e560 (2-).
  • 51
    Bautista E, Simons FE, Simons KJ, Becker AB, Duke K, Tillett M et al. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol 2002;128:1564 (1-).
  • 52
    Kim JS, Sinacore JM, Pongracic JA. Parental use of EpiPen for children with food allergies. J Allergy Clin Immunol 2005;116:164168 (3).
  • 53
    Pouessel G, Deschildre A, Castelain C, Sardet A, Sagot-Bevenot S, De Sauve-Boeuf A et al. Parental knowledge and use of epinephrine auto-injector for children with food allergy. Pediatr Allergy Immunol 2006;17:221226 (2-).
  • 54
    Simons FER, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998;101:3337 (1+).
  • 55
    Simons FER, Chan ES, Gu X, Simons KJ. Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical?. J Allergy Clin Immunol 2001;108:10401044 (2+).
  • 56
    Lieberman P, Kemp F, Oppenheimer J, Lang DM, Berstein L, Nicklas A et al. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy clin Immunol 2005;115:54835523 (2++).
  • 57
    Brown SGA. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005;5:359364 (4).
  • 58
    Nolan J, Baskett P. ERC Guidelines for Resuscitation 2005. Oxford: Elsevier, 2005.
  • 59
    American Heart Association. Anaphylaxis. Circulation 2005;112 (Suppl. 1):143145 (2++).
  • 60
    Simons FER, Gu X, Johnston LM, Simons KJ. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis?. Pediatrics 2000;106:10401044 (1+).
  • 61
    Spivey WH, Crespo SG, Fuhs LR, Schoffstall JM. Plasma catecholamine levels after intraosseous epinephrine administration in a cardiac arrest model. Ann Emerg Med 1992;21:127131 (1+).
  • 62
    Rawas-Qalaji MM, Simons FER, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol 2006;117:398403 (2-).
  • 63
    Perondi MB, Reis AG, Paiva EF, Nadkarni VM, Berg RA. A comparison of high-dose and standard-dose epinephrine in children with cardiac arrest. N Engl J Med 2004;350:17221730 (1+).
  • 64
    Sheikh A, Ten Broek V, Brown S, Simons F. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2007;CD006160.
  • 65
    Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 2000;36:462468 (1+).
  • 66
    Mayumi H, Kimura S, Asano M, Shimokawa T, Au-Yong TF, Yayama T. Intravenous cimetidine as an effective treatment for systemic anaphylaxis and acute allergic skin reactions. Ann Allergy 1987;58:447450 (2).
  • 67
    Zaloga G, Delacey W, Holmboe E, Chernow B. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Int Med 1986;105:6566 (3).
  • 68
    Javeed N, Javeed H, Javeed S, Moussa G, Wong P, Rezai F. Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn 1996;39:383384 (3).
  • 69
    Brown SGA, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis?. Emerg Med Australas 2004;16:120124 (1+).
  • 70
    Host A, Andrae S, Charkin S, Diaz-Vazquez C, Dreborg S, Eigenmann PA et al. Allergy testing in children: why, who, when and how?. Allergy 2003;58:559569 (2++) (Comprehensive systematic review).
  • 71
    Christie L, Hine RJ, Parker JG, Burks WJ. Food allergies in children affect nutrient intake and growth. J Am Diet Ass 2002;102:16481651 (2+).
  • 72
    Roberts G, Lack G. Diagnosing peanut allergy with skin prick and specific IgE testing. J Allergy Clin Immunol 2005;115:12911296 (2-).
  • 73
    Sporik R, Hill DJ, Hosking CS. Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in children. Clin Exp Allergy 2000;30:15401546 (2+).
  • 74
    Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenger in children and adolescents. J Allergy Clin Immunol 1997;100:444451 (2+).
  • 75
    Celik-Bilgili S, Mehl A, Verstege A, Staden U, Nocon M, Beyer K et al. The predictive value of specific immunoglobulin E levels in serum for the outcome of oral food challenges. Clin Exp Allergy 2005;35:268273 (2++).
  • 76
    Verstege A, Mehl A, Rolinck-Werninghaus C, Staden U, Nocon M, Beyer K et al. The predictive value of the skin prick test wheal size for the outcome of oral food challenges. Clin Exp Allergy 2005;35:12201226 (2).
  • 77
    Beyer K, Teuber S. Food allergy diagnostics: scientific and unproven procedures. Curr Opin Allergy Clin Immunol 2005;5:261266 (4).
  • 78
    Shreffler WG, Beyer K, Burks AW, Sampson HA. Microarray immunoassays: association of clinical history, in vitro IgE function and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 2004;113:776782 (2+).
  • 79
    Mills ENC, Valovirta E, Madsen C et al. Information provision for allergic consumers – where are we going with food allergen labelling. Allergy 2004;59: 12621268 (4).
  • 80
    Parlement Européen et Conseil. Directive 2003/89/CE, Directive 2003/89/CE du parlement Européen et du conseil du 10 novembre 2003. Journal officiel de l’Union Européenne 2003; p.NoL 308:15–18 (4).
  • 81
    Commission Européenne. European Directive 2005/26/CE. Journal Officiel des Communautés européennes n 2005: No L 75 du 22/03/2005/1334.
  • 82
    Moneret-Vautrin DA, Kanny G. Update on threshold doses of food allergens: implications for patients and the food industry. Curr Opin Allergy Clin Immunol 2004;4:215219 (4).
  • 83
    Sicherer SH, Furlong TJ, DeSimone J, Sampson HA. The US Peanut and Tree Nut Allergy Registry: characteristics of reactions in schools and day care. J Pediatr 2001;138:560565 (2-).
  • 84
    Kapoor S, Roberts G, Bynoe Y, Gaughan M, Habibi P, Lack G. Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions. Allergy 2004;59:185191 (3).
  • 85
    Moffitt JE, Golden DB, Reisman RE, Lee R, Nicklas R, Freeman T et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol 2004;114:869886 (2++) (Comprehensive systematic review).
  • 86
    Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U. EAACI Interest Group on insect venom hypersensitivity prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005;60:14591470 (4).
  • 87
    Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E. EAACI, Immunotherapy Task Force Standards for practical allergen-specific immunotherapy. Allergy 2006;61(Suppl. 82):120 (2++).
  • 88
    Parmar JS, Nasser S. Antibiotic allergy in cystic fibrosis. Thorax 2005;60:517520 (4).
  • 89
    Cullinan P, Brown R, Field A, Hourihane J, Jones M, Kekwick R et al. Latex allergy a position paper of the British Society of Allergy and Clinical Immunology. Clin Exp Allergy 2003;33:14841499 (4).
  • 90
    Watura JC. Allergy in schoolchildren: a survey of schools in the Severn. NHS TrustArch Dis Child 2002;86:240244 (2-).
  • 91
    Boros CA, Kay D, Gold MS. Parent reported allergy and anaphylaxis in 4173 South Australian children. J Paed Child Health 2000;36:3640 (2-).
  • 92
    Rhim GS, McMorris MS. School readiness for children with food allergies. Ann Allergy Asthma Immunol 2001;86:172176 (2-).
  • 93
    Patel BM, Bansal PJ, Tobin MC. Management of anaphylaxis in child care centers: evaluation 6 and 12 months after an intervention program. Ann Allergy Asthma Immunol 2006;97:813815 (2-).
  • 94
    Simons FE, Gu X, Simons KJ. Outdated EpiPen and EpiPen Jr autoinjectors: past their prime?. J Allergy Clin Immunol 2000;105:10251030 (1+).
  • 95
    Simons FE, Gu X, Silver NA, Simons KJ. EpiPen Jr versus EpiPen in young children weighing 15–30 kg at risk for anaphylaxis. J Allergy Clin Immunol 2002;109:171175 (1+).
  • 96
    Global Initiative for Asthma (GINA) Report 2006. systematic review) (Accessed 21 January 2007) (2++).
  • 97
    Roberts G, Golder N, Lack G. Bronchial challenges with aerosolized food in asthmatic children with food allergy. Allergy 2002;57:713717 (3).
  • 98
    Uguz A, Lack G, Pumphrey R, Ewan P, Warner JO, Dick J et al. Allergic reaction in the community: a questionnaire survey of members of the anaphylaxis campaign. Clin Exp Allergy 2005;35:746750 (2-).
  • 99
    Blyth TP, Sundrum R. Adrenaline autoinjectors and schoolchildren: a community based study. Arch Dis Child 2002;86:2627 (2-).
  • 100
    Goldberg A, Confino-Cohen R. Insect sting-inflicted systemic reactions: attitudes of patients with insect venom allergy regarding after-sting behaviour and proper administration of epinephrine. J Allergy Clin Immunol 2000;106: 11841189 (2+).
  • 101
    Huang SW. A survey of Epi-PEN use in patients with a history of anaphylaxis. J Allergy Clin Immunol 1998;102:525526 (3).
  • 102
    Ewan PW, Clark AT. Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice. Clin Exp allergy 2005;35:751756 (2+).
  • 103
    Elberink JN, Van der Heide S, Guyatt Gordon GH, Dubois Anthony EJ. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. J Allergy Clin Immunol 2006;118:699704 (1++).
  • 104
    Skorpinski EW, McGeady SJ, Yousef E. Two cases of accidental epinephrine injection into a finger. J Allergy Clin Immunol 2006;117:463464 (3).
  • 105
    Jarvinen KM, Shreffler WG, Sampson HA, Noone S. Novak-Wegrzyn. Use of epinephrine in food – induced anaphylaxis. J.Allergy Clin Immunol 2007;119:S29, 110 (3).
  • 106
    Kelso JM. A second dose of epinephrine for anaphylaxis: how often needed and how to carry. J Allergy Clin Immunol 2006;117:464465 (4).
  • 107
    Oren E, Banerji A, Clark S, Camargo CA. Food- induced anaphylaxis and repeat epinephrine treatments. J Allergy Clin Immunol 2007;119:S114, 449t (3).
  • 108
    Vickers DW, Maynard L, Ewan PW. Management of children with potential anaphylactic reactions in the community: a training package and proposal for good practice. Clin Exp Allergy 1997;27:898903 (3).
  • 109
    Sicherer SH. Determinants of systemic manifestations of food allergy. J Allergy Clin Immunol 2000;5(Suppl):S251S257 (4).
  • 110
    Arkwright PD, Farragher AJ. Factors determining the ability of parents to effectively administer intramuscular adrenaline to food allergic children. Pediatr Allergy Immunol 2006;17:227229 (2-).
  • 111
    Grouhi M, Alshehri M, Hummel D, Roifman CM. Anaphylaxis and epinephrine auto-injector training: who will teach the teachers?. J Allergy Clin Immunol 1999;104:190193 (2+).
  • 112
    Ferreira MB, Alves RR. Are general practitioners alert to anaphylaxis diagnosis and treatment?. Allergy Immunol 2006;38:8386 (3).
  • 113
    Ewan PW, Clark AT. Long-term prospective observational study of patients with peanut and peanut allergy after participation in a management plan. Lancet 2001;357:111115 (2+).
  • 114
    Moneret-Vautrin DA, Kanny G, Morisset M, Flabbee J, Guenard L, Beaudouin E et al. Food anaphylaxis in schools: evaluation of the management plan and the efficiency of the emergency kit. Allergy 2001;56:10711076 (2-).
  • 115
    Baumgart K, Brown S, Gold M, Kemp A, Loblay R, Loh R et al. Australasian Society of Clinical Immunology and Allergy Anaphylaxis Working Party ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child-care centres. J Paediatr Child Health 2004;40:669671 (4).
  • 116
    AAAAI Board of Directors. Anaphylaxis in schools and other child-care settings. J Allergy Clin Immunol 1998;102:173176 (4).
  • 117
    Murphy KR, Hopp RJ, Kittelson EB, Hansen G, Windle ML, Walburn JN. Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs. Ann Allergy Asthma Immunol 2006;96:398405 (2-).
  • 118
    Mc Intyre L, Sheetz AH, Carrol CR, Young MC. Administration of epinephrine for life-threatening allergic reactions in school settings. Pediatric 2005;116:11341140 (3).
  • 119
    Priscoll D. Managing life threatening food allergies in school. Malden: Massachussets Department of Education. Commissioner of Education, 2002.
  • 120
    Ferry L, Sarkozy N, Mattei JF, Gaymard H, Darcos X, Jacob C. Circulaire projet d’accueil n° 2003-135 du 08/09/2003 (Bulletin Officiel du ministère de l'Education Nationale et du ministère de la Rercherche n° 34 du 18/9/2003).
  • 121
    Lang J, Fabius L, Glavany J, Guigou E, Vaillant D, Kouchner B et al. Exemple de projet d'Accueil individualisé. Circulaire restauration scolaire n° 2001-118 du 25/06/2001. (Bulletin Officiel du ministère de l'Education Nationale et du ministère de la Rercherche Spécial n° 9 du 28/06/2001).
  • 122
    Olympia RP, Wan E, Avner JR. The preparedness of schools to respond to emergencies in children: a national survey of school nurses. Pediatrics 2005;116:e738e745 (2+).
  • 123
    Barnett CW. Need for community pharmacists-provide food allergy education and auto-injectable epinephrine training. J Am Pharm Assoc 2005;45:479485 (2-).